Prima di Memmo, i miei appunti erano sparsi tra mille PDF. Ora uno spazio di lavoro raccoglie tutto in un unico posto, e vedo esattamente cosa mi resta da studiare.
The state of the art in biopharmaceutical FUSION PROTEIN DESIGN
Fusion proteins belong to the most lucrative biotech drugswith Enbrel® being one of the best-selling biologics worldwide. Enbrel® represents a milestone of modern therapies just as Humulin®, the first therapeutic recombinant protein for human use, approved by the FDA in 1982 and Orthoclone® the first monoclonal antibody reaching the market in 1986. These first generation molecules were soon followed by a plethora of recombinant copies of natural human proteins, and in 1998, the first de novo designed fusion protein was launched.
Fusion Protein Technologies for Biopharmaceuticals examines the state of the art in developing fusion proteins for biopharmaceuticals, shedding light on the immense potential inherent in fusion protein design and functionality. A wide pantheon of international scientists and researchers deliver a comprehensive and complete overview of therapeutic fusion proteins, combining the success stories of marketed drugs with the dynamic preclinical and clinical research into novel drugs designed for as yet unmet medical needs.
The book covers the major types of fusion proteinsreceptor-traps, immunotoxins, Fc-fusions and peptibodieswhile also detailing the approaches for developing, delivering, and improving the stability of fusion proteins. The main body of the book contains three large sections that address issues key to this specialty: strategies for extending the plasma half life, the design of toxic proteins, and utilizing fusion proteins for ultra specific targeting. The book concludes with novel concepts in this field, including examples of highly relevant multifunctional antibodies.
Detailing the innovative science, commercial realities, and brilliant potential of fusion protein therapeutics, Fusion Protein Technologies for Biopharmaceuticals is a must for pharmaceutical scientists, biochemists, medicinal chemists, molecular biologists, pharmacologists, and genetic engineers interested in determining the shape of innovation in the world of biopharmaceuticals.
Prima di Memmo, i miei appunti erano sparsi tra mille PDF. Ora uno spazio di lavoro raccoglie tutto in un unico posto, e vedo esattamente cosa mi resta da studiare.
I riassunti di Memmo sono oro puro prima degli esami. Non devo rileggere 800 pagine due settimane prima, solo le parti importanti.
La chat AI mi ha salvato più di una volta la sera prima di un esame. Continuo a chiedere finché non capisco, senza aspettare risposte da un gruppo di studio.
I quiz colpiscono esattamente ciò che devo sapere. Memmo tiene traccia di dove mi blocco, così mi esercito solo su ciò che conta davvero.
Le flashcard con ripetizione spaziata sono magia pura. Memmo sa quando sto per dimenticare qualcosa e me lo ripropone.
I podcast AI sono i miei preferiti. Li ascolto mentre vado a scuola e ripasso senza stare davanti al computer.
Handbok i kvalitativa metoder
281 kr
Hållbar utveckling: en introduktion för ingenjörer och andra problemlösare
334 kr
Brymans Samhällsvetenskapliga metoder
390 kr
Projektledning
491 kr
Den orättvisa hälsan: om socioekonomiska skillnader i hälsa och livslängd
326 kr
Organizational Leadership
429 kr
Vetenskapsteori för nybörjare
196 kr
På väg mot läraryrket
172 kr
Det sociala livet i skolan: Socialpsykologiska perspektiv
253 kr
Betygsättningens didaktik
151 kr
Personality
402 kr
Studying Leadership
404 kr
Managing Innovation
477 kr
Introduktion till samhällsvetenskaplig metod
347 kr
The Psychology of Sex and Gender
698 kr
Introduction to Leadership
605 kr
Evidens och kunskap för socialt arbete
207 kr